Advancements in the management of overactive bladder in women using nano-botulinum toxin type A: A narrative review
Abstract. Intravesical injections of botulinum toxin type A (BTX-A) are effective for treating refractory overactive bladder (OAB) in women. However, the adverse effects linked to the injections, such as hematuria, pain, and infection, and need for repeated injections can lower patient compliance an...
Saved in:
| Main Authors: | Yongheng Zhou, Qinggang Liu, Huiling Cong, Limin Liao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health
2025-03-01
|
| Series: | Current Urology |
| Online Access: | http://journals.lww.com/10.1097/CU9.0000000000000272 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of intravesical instillation of botulinum toxin-A in the treatment of interstitial cystitis/bladder pain syndrome and overactive bladder: a systematic review and meta-analysis
by: Yongheng Zhou, et al.
Published: (2025-04-01) -
Ultrasound guided transabdominal botulinum toxin injection for refractory overactive bladder treatment
by: Junhua Li, et al.
Published: (2025-05-01) -
Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
by: Brian L. Cohen, et al.
Published: (2009-01-01) -
The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01) -
The role of botulinum toxin in the management of nonneurogenic overactive bladder in children: Highlights for clinical practice. A systematic review
by: José A. Câncio Martins Bissaia Barreto, et al.
Published: (2024-03-01)